바이오의약품 제3자 물류 시장 규모, 점유율, 동향 분석 : 공급망별(콜드체인, 비콜드체인) , 서비스 종류별(수송, 창고와 보관) , 지역별, 부문별 예측(2022-2030년)
Biopharmaceutical Third-party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service Type (Transportation, Warehousing & Storage), By Region, And Segment Forecasts, 2022 - 2030
상품코드 : 1097011
리서치사 : Grand View Research, Inc.
발행일 : 2022년 06월
페이지 정보 : 영문 114 Pages
US $ 5,950 ₩ 8,560,000
Unprintable PDF (Single User License)
US $ 6,950 ₩ 9,999,000
Printable PDF (5-User License)
US $ 8,950 ₩ 12,877,000
Printable PDF (Enterprise License)


한글목차

바이오의약품 제3자 물류 시장 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 의하면 세계의 바이오의약품 제3자 물류(Biopharmaceutical Third-party Logistics) 시장 규모는 2030년까지 1,985억 달러에 달하고, 예측기간 중 CAGR 5.9%로 성장할 것으로 예측됩니다.

다양한 지역에서 생물제제를 수송하기 위한 온도 관리된 물류 서비스에 대한 수요 증가와 판매 향상을 위한 바이오의약품 기업의 유통망 확대가 바이오의약품 제3자 물류(3PL) 시장 성장을 촉진하는 요인이 되고 있습니다. 신흥국의 자동 보관·검색 시스템 채용 상승은 의약품 물류 기업에 있어서 큰 견인력을 보유한 지속적인 동향입니다. 주요 시장 참여자는 공급 두절을 최소한으로 억제하고, 중요한 치료제를 우선하여 COVID-19와의 싸움에서 중요한 역할을 완수했습니다.

바이오의약품 제3자 물류 시장 보고서 하이라이트:

목차

제1장 조사 방법

제2장 주요 요약

제3장 바이오의약품 제3자 물류 시장 변수, 동향, 범위

제4장 바이오의약품 제3자 물류 시장 : 공급망 추정·동향 분석

제5장 바이오의약품 제3자 물류 시장 : 서비스 종류 추정·동향 분석

제6장 바이오의약품 제3자 물류 시장 : 지역 추정과 동향 분석

제7장 경쟁 상황

KSM 22.07.14
영문 목차

영문목차

Biopharmaceutical Third-party Logistics Market Growth & Trends:

The global biopharmaceutical third-party logistics market size is expected to reach USD 198.5 billion by 2030, growing at a CAGR of 5.9% over the forecast period, according to a new report by Grand View Research, Inc. The rising demand for temperature-controlled logistic services to transport biologics in various regions and growing distribution networks of biopharmaceutical companies to improve their sales are factors driving the biopharmaceutical third-party logistics (3PL) market growth. The rising adoption of automated storage and retrieval systems in emerging countries is an ongoing trend in the pharmaceutical logistics companies that have gained significant traction. The key market players played a vital role in the fight against COVID-19 by minimizing supply disruptions and prioritizing critical care drugs.

A sudden surge in the demand for cold chain logistics was observed during the pandemic because of the manufacturing and distribution of COVID-19 vaccines. The future also seems good for the global market with the rising demand for domestic logistics coupled with favorable government initiatives and policies. Furthermore, the trend of shifting from small molecule drugs to biopharmaceuticals, mainly vaccines, and biologics, is projected to drive the market. Since these small molecule drugs are temperature-sensitive products, demand for temperature-controlled transportation and storage increases and thus is responsible for the market growth.

Moreover, environmental concerns and costs have caused a slight shift in the means of transport used for commercial products, moving from airway to seaway shipping and in roadways from truck to intermodal (both rail and truck). Intermodal transport is majorly used by these pharmaceutical companies to reduce their carbon footprint. The ongoing trend shows that pharmaceutical manufacturers have shifted towards sea freight to reduce the cost and risk factors. Although for cold chain products, the companies still prefer air freight. However, some of the large pharmaceutical companies are planning to transport 70% of their products via ocean freight including cold chain products.

Biopharmaceutical Third-party Logistics Market Report Highlights:

Table of Contents

Chapter 1. Research Methodology

Chapter 2. Executive Summary

Chapter 3 Biopharmaceutical Third Party Logistics Market Variables, Trends & Scope

Chapter 4. Biopharmaceutical Third Party Logistics Market: Supply Chain Estimates & Trend Analysis

Chapter 5. Biopharmaceutical Third Party Logistics Market: Services Type Estimates & Trend Analysis

Chapter 6. Biopharmaceutical Third Party Logistics Market: Regional Estimates & Trend Analysis

Chapter 7. Competitive Landscape

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기